Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
What U.S. Obstetricians Need to Know About Respiratory Syncytial Virus
This review article discusses two preventive option for the prevention of RSV in infants: a maternal vaccine and a monoclonal antibody for infants. The FDA …
Ask aRCie
Respiratory Syncytial Virus (RSV): Advisory Committee on Immunization Practices (ACIP) Recommendations
2024
· Johns Hopkins University
The Advisory Committee on Immunization Practices (ACIP) provides guidelines for preventing Respiratory Syncytial Virus (RSV). Infants up to 8 months should get a dose of …
The Latest in RSV Protection for Kids: An Antibody Treatment Called Beyfortus
2023
· Johns Hopkins University
This article describes a new drug called Beyfortus that helps protect babies and toddlers from RSV, a virus causing serious illness in young children. Approved …
New Monoclonal Antibody Prevents RSV in Infants and Toddlers
This article discusses the approval of the monoclonal antibody nirsevimab-alip (Beyfortus) to prevent respiratory syncytial virus (RSV) in high-risk neonates and infants up to 24 …
Preventing Respiratory Syncytial Virus (RSV) Disease in Children
2021
· Johns Hopkins University
This brief perspective article discusses the progress and promising strategies for RSV immunization to combat the significant burden of RSV infection in young children globally. …
Respiratory Syncytial Virus Prevention: A New Era of Vaccines
2023
· Jiangsu University,
· University of Massachusetts,
· Mayo Clinic,
· Johns Hopkins University,
· Rochester Regional Health,
· Mir Neurology
This editorial discusses new vaccines for preventing respiratory syncytial virus (RSV) infections. RSV affects the lungs and can be serious, especially in young children and …